A photo of Adam Lane.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics

513-803-1828

513-803-1969

Biography & Affiliation

Biography

Dr. Lane joined Cincinnati Children's in July 2013. He has published novel statistical methods in the areas of adaptive and optimal experimental designs with applications to phase I and phase II clinical trials. As a graduate student he received funding from the NIH to spend the fall semester of 2011 at the University of Cambridge in the Isaac Newton Institute for Mathematical Sciences. He has also received NSF travel awards to present his research at national and international conferences.

Research Interests

Clinical trials; survival analysis; structural equation modeling

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Research Divisions

Experimental Hematology and Cancer Biology, Cancer and Blood Diseases



Blog Posts

Education

PhD: University of Missouri, Columbia, MO, 2013.

Publications

Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease. Wallace, G; Khandelwal, P; Myers, KC; Perentesis, EM R; Lane, A; Teusink-Cross, A; Smiley, K; Davies, SM; Jodele, S. Bone Marrow Transplantation. 2021; 56:1441-1444.

Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution. Hughes, K; Garrity, L; Nelson, AS; Lane, A; Teusink-Cross, A. Pediatric Transplantation. 2021; 25.

HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening. Bedard, MC; de Alarcon, A; Kou, YF; Lee, D; Sestito, A; Duggins, AL; Brusadelli, M; Lane, A; Wikenheiser-Brokamp, KA; Wells, SI; et al. Cancers. 2021; 13.

Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; et al. Haematologica. 2021; 106:1321-1329.

Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Wang, YZ M; Howell, JC; Grimley, MS; Lane, A; Davies, SM; Myers, KC. Pediatric Transplantation. 2021; 25.

Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Khandelwal, P; Yeh, RF; Yu, L; Lane, A; Dandoy, CE; El-Bietar, J; Davies, SM; Grimley, MS. Transplantation. 2021; 105:891-896.

Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy. Mullins, ES; Geer, R; Metcalf, M; Piccola, J; Lane, A; Conard, LA E; Kowalczyk Mullins, TL. Pediatrics. 2021; 147.

A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Dandoy, CE; Rotz, S; Alonso, PB; Klunk, A; Desmond, C; Huber, J; Ingraham, H; Higham, C; Dvorak, CC; Duncan, C; et al. Blood Advances. 2021; 5:1-11.

Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; et al. Blood Advances. 2021; 5:250-261.

Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis. Bedard, MC; Brusadelli, MG; Carlile, A; Ruiz-Torres, S; Lodin, H; Lee, D; Kofron, M; Lambert, PF; Lane, A; Ameziane, N; et al. Viruses. 2021; 13.